HomeNews

News

September Blood Most cancers Updates: What Sufferers Ought to Know

As September concludes, the panorama of hematologic oncology continues to evolve, spanning the total spectrum of blood most cancers care. Latest scientific...

FDA Approves Guardant360 Check With Inluriyo for ESR1 Breast Most cancers

The U.S. Meals and Drug Administration (FDA) has accepted its Guardant360® CDx as a companion diagnostic to establish sufferers with superior breast most...

2025 Quarter 3 – COA Affected person Advocacy Community Information Bulletin

A Word from the Director of Affected person Advocacy & TrainingCPAN begins the fourth quarter with a continued give attention to its...

Pelvic Bodily Remedy After Most cancers Restores Intimacy, Wellness

Alison Ankiewicz, a pelvic well being specialist with 27 years of expertise and a childhood leukemia survivor, explains how pelvic bodily remedy...

Esophageal Most cancers, From Prognosis to Therapy

A prognosis of esophageal most cancers can convey up many questions and issues. Our objective is to give you clear, correct and...

Hot Topics